ArticleJournal of health economics and outcomes research2026
The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis.
Ana Teresa Paquete et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.